e-learning
resources
Munich 2006
Tuesday 05.09.2006
Matrix remodelling at the interface of lung fibrosis and emphysema
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Molecular imaging of the progression of pulmonary fibrosis using animal models of disease
R. Labiris, K. Ask, T. Farncombe, R. Chirakal, M. Kolb (Hamilton, Canada)
Source:
Annual Congress 2006 - Matrix remodelling at the interface of lung fibrosis and emphysema
Session:
Matrix remodelling at the interface of lung fibrosis and emphysema
Session type:
Oral Presentation
Number:
3557
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Labiris, K. Ask, T. Farncombe, R. Chirakal, M. Kolb (Hamilton, Canada). Molecular imaging of the progression of pulmonary fibrosis using animal models of disease. Eur Respir J 2006; 28: Suppl. 50, 3557
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Lane-hamilton syndrome and CCF: a fatal association
Imaging of complicated pneumonia: what is new?
Related content which might interest you:
3he MRI and an animal model of interstitial lung disease
Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities
Year: 2009
Molecular mechanisms of lung tissue remodeling in progression of idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010
Biological- and imaging biomarkers of edema and fibrosis in a rat model of drug-induced interstitial lung disease (DIILD)
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019
Preclinical models and imaging biomarkers of lung injury and disease
Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease
Year: 2021
Use of PET/CT to evaluate pulmonary inflammation and fibrosis in an animal model
Source: Eur Respir J 2006; 28: Suppl. 50, 606s
Year: 2006
Interstitial pulmonary fibrosis model develpment and identification of early biomarkers by MALDI imaging
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Morphologic evaluation of lung in a scleroderma-like rabbit model
Source: Annual Congress 2006 - Systemic diseases, environmental and genetic factors in interstitial lung disease
Year: 2006
The pathogenesis of pulmonary fibrosis: a moving target
Source: Eur Respir J 2013; 41: 1207-1218
Year: 2013
Novel imaging biomarkers for assessment of lung fibrosis and inflammation
Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease
Year: 2021
Tomographic pattern and disease progress or mortality in familial pulmonary fibrosis
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
Endotrophin is related to disease progression in idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020
Elucidating progression of early cystic fibrosis lung disease
Source: Eur Respir J, 50 (5) 1701916; 10.1183/13993003.01916-2017
Year: 2017
Volumetric CT analysis of normal lung as a predictor of mortality in idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent
Source: Eur Respir J, 55 (4) 1901519; 10.1183/13993003.01519-2019
Year: 2020
Imaging biomarkers of oedema and fibrosis in a rat model of Drug-Induced-ILD
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: mechanistic insights and prognostic markers
Year: 2018
Prediction of survival in interstitial lung disease (ILD); role of DTPA lung clearance scans and lung function variables
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Non-invasive molecular imaging of pulmonary fibrosis
Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease
Year: 2018
A humanized animal model of pulmonary fibrosis based on cellular senescence
Source: Virtual Congress 2020 – Cellular involvement in lung injury
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept